While the possibility of technical error was considered, the observed increase in CWI in this study aligns with the elevated expression of established genetic markers of cardiac hypertrophy, including NPPA, NPPB, and MAPK1; a key component of the pro-hypertrophic RAS-MAPK signalling pathway. This evidence concerns the gene MAPK1 and cardiac hypertrophy.